Aridis Pharmaceuticals Announces 2021 Fourth Quarter and Year-End Financial Results and Business Update

/PRNewswire/ -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective...

Related Keywords

Russia ,India ,Ukraine ,Los Gatos ,Vu Truong ,Aridis Pharmaceuticals ,Aridis Pharmaceuticals Inc ,Prnewswire Aridis Pharmaceuticals Inc ,Cystic Fibrosis Foundation ,Innovative Medicines Initiative ,Nasdaq ,Development Expenses ,Us Small Business Administration ,Astrazeneca ,Paycheck Protection Program ,Serum Institute Of India ,Clinical Program ,Redchip Companies ,Company Phase ,Melinda Gates Foundation ,European Commission ,Drug Administration ,Data Monitoring Committee ,Cf Foundation ,Exchange Commission ,European Medicines Agency ,Shenzhen Arimab Biopharmaceuticals Co Ltd ,Gates Foundation ,Ventilator Associated Pneumonia ,Severe Acute Respiratory Syndrome ,Middle East Respiratory Syndrome Coronavirus ,Chief Executive Officer ,Eastern Europe ,Scientific Advisory ,Orphan Drug Designation ,Fast Track ,Qualified Infectious Disease Product ,Cystic Fibrosis ,Administrative Expenses ,Equity Method ,Protection Program ,Lancet Infectious Diseases ,Serum Institute ,Months Ended ,Nc ,